23 August 2023
Neurocrine Biosciences, Inc. announced the U.S. Food and Drug Administration (FDA) has approved INGREZZA ® (Valbenazine) capsules for treatment of
Read more
25 April 2023
Dear Huntington disease (HD) community, We have received an update on PROOF-HD, the phase 3, randomized, double-blind, placebo-controlled study to
Read more
6 April 2023
Do you like feel-good news? We know you’ll love this fabulous Huntington disease (HD) update. Thanks to our generous donors,
Read more
8 December 2022
Update From Novartis Regarding VIBRANT-HD Clinical Trials – December 8, 2022 Dear Huntington disease (HD) community, We have received a
Read more
Our Shining Stars virtual tribute wall honours those who have been touched in some way by HD. Please see our Shining Stars on our Shining Stars Universe, Galaxy and Solar System pages.
Family is at the heart of our community. Our families and volunteers tell a powerful story of caring people who pull together to improve the quality of life of Canadians impacted by Huntington disease (HD). At the HSC, we work with individuals who have HD, as well as people who are caring for someone with HD, are gene positive or gene negative or are at-risk of inheriting HD. We are a not-for-profit charitable organization which raises funds to deliver counselling and other support services to individuals and families living with HD. We fund peer reviewed medical research leading to treatments and we work with health and social services professionals to enable them to better serve people living with HD.
Highlights from the 2020 CHDI HD Therapeutics Conference are now here! This year’s Postcard covers HTT-lowering therapeutics, including an
Read more
Stay in Touch!
Enter your email address below to receive occasional updates.
